Scott Shuda has bought stock on 8 days since Aug 2018

Scott Shuda is a corporate insider and seasoned investment professional who serves as Executive Chairman of the Board of Directors at Iridex Corporation (IRIX), a global leader in ophthalmic laser-based medical systems for the treatment of retinal diseases and glaucoma.( He has been a member of Iridex’s board since April 2019 and previously served as chairman of the board before his appointment as Executive Chairman in 2024, building on earlier service as a director of the company from 2012 to 2017.( Shuda’s recent insider trading activity in Iridex reflects his ongoing role in corporate governance and shareholder oversight.(

Shuda is Managing Director and Co‑founder of Meridian OHC Partners, LP and BlueLine Partners, LLC, investment firms focused on publicly listed technology and healthcare companies, and he has also been identified as Managing Director at TSV Investment Partners LLC.( In addition to his Iridex responsibilities, he serves on the board of InfuSystem Holdings, Inc., a provider of ambulatory infusion pumps, where he has held director and chairman roles over multiple years.( He brings more than two decades of experience in investment management, board leadership, and shareholder representation to these positions.( Shuda holds both a Juris Doctor (J.D.) and Master of Business Administration (MBA) from Georgetown University, a dual qualification that underpins his expertise in corporate governance, finance, and strategic transactions.(

Written by Perplexity from public sources.